Title: Global pharmas keep eyes on Daedeok, the center of bio venture companies

Publication:  Daedeok-net / Yang Soo Kim

Date: 27 November 2008

Summary 

• Barely over 2 years after its inception, LegoChem registered 6 patents in new drug development.               

• LegoChem, bynamed "the little LG Life Sciences", with hoarded experiences in novel drug development with global expertise, is nestled in Daedeok Innopolis. 

• The pharmaceutical market has been monopolized by a few developed countries but LegoChem challenges the stream - the company has already successfully discovered drug candidates after lead generation. 

• Vice President SeJin Park said "Our goal is to develop a globally competitive new drug that no other has ever made," and "we would conduct toxicity test for antibiotic candidate with the support of the government fund while seeking to out-license to global partners."

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).